Clinical trial
MOTIV Study. Effect of Antidepressive Treatment by Escitalopram Started Preoperatively in Patients Undergoing Coronary Artery Bypass Grafting
NCT00243477 is registered in ClinicalTrials.gov with Hopital Jean Minjoz as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MOTIV Study. Effect of Antidepressive Treatment by Escitalopram Started Preoperatively in Patients Undergoing Coronary Artery Bypass Grafting
- Lead sponsor
- Hopital Jean Minjoz
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2006
- Completion date
- February 29, 2012
- Enrollment
- 368 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.